PTK2 and cancer: Previously, ITGBL1 was reported to promote metastasis in various types of cancers by controlling either Wnt-PCP signaling or the FAK/SRC or TGF-β signaling pathways (Berg et al. 1999; Gan et al. 2016; Li et al. 2015; Sun et al. 2016).